SOLTI NeoPARP: a phase II randomized study of two schedules...

Breast Cancer Research and Treatment 2015 / 11 Vol. 154; Iss. 2

SOLTI NeoPARP: a phase II randomized study of two schedules of iniparib plus paclitaxel versus paclitaxel alone as neoadjuvant therapy in patients with triple-negative breast cancer

Llombart-Cussac, Antonio, Bermejo, Begoña, Villanueva, Cristian, Delaloge, Suzette, Morales, Serafín, Balmaña, Judith, Amillano, Kepa, Bonnefoi, Hervé, Casas, Ana, Manso, Luis, Roché, Henri, Gonzalez-
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
154
Language:
english
Journal:
Breast Cancer Research and Treatment
DOI:
10.1007/s10549-015-3616-8
Date:
November, 2015
File:
PDF, 402 KB
english, 2015
Conversion to is in progress
Conversion to is failed